The big problem of small data: A new approach

Big Data is all the rage today, but Small Data matters too! Drawing reliable conclusions from small datasets, like those from clinical trials for rare diseases or in studies of endangered species, remains one of the trickiest ...

Two steps ahead—neutrons help explore future HIV treatments

Human immunodeficiency virus (HIV) is a quick learner. As fast as researchers get effective anti-viral drugs into clinical trials, the virus evolves, deploying potent resistance mutations that render the medicine useless ...

Cannabidiol: Hope or hype?

Cannabidiol (CBD), one of the major phytochemicals in marijuana, has become a popular ingredient in dietary supplements, beauty products and beverages, with claims that the compound improves health and treats ailments ranging ...

FDA approves first artificial iris

(HealthDay)—The first artificial iris has been approved by the U.S. Food and Drug Administration for patients with aniridia.

page 20 from 27